Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,723 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease.
Shinzaki S, Fujii T, Bamba S, Ogawa M, Kobayashi T, Oshita M, Tanaka H, Ozeki K, Takahashi S, Kitamoto H, Kani K, Nanjo S, Sugaya T, Sakakibara Y, Inokuchi T, Kakimoto K, Yamada A, Yasuhara H, Yokoyama Y, Yoshino T, Matsui A, Nakamura M, Tomizawa T, Sakemi R, Kamata N, Hibi T. Shinzaki S, et al. Among authors: ogawa m. Intest Res. 2018 Oct;16(4):609-618. doi: 10.5217/ir.2018.00044. Epub 2018 Oct 10. Intest Res. 2018. PMID: 30301329 Free PMC article.
Comparison of the effects of individual symptoms of gastroesophageal reflux disease co-existing functional dyspepsia on patients' daily lives: A prospective, observational study.
Nakada T, Isshi K, Matsuhashi N, Iwakiri K, Kamiya T, Manabe N, Higuchi K, Joh T, Oshio A, Ogawa M, Hokari A, Saruta M, Haruma K, Nakada K. Nakada T, et al. Among authors: ogawa m. JGH Open. 2022 Nov 5;6(12):886-893. doi: 10.1002/jgh3.12837. eCollection 2022 Dec. JGH Open. 2022. PMID: 36514504 Free PMC article.
Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report.
Arai Y, Ogawa M, Yamane F, Sumiyoshi N, Arimoto R, Ando Y, Endo D, Nakada T, Sugawara I, Yokoyama H, Shimoyama K, Inomata H, Kawahara Y, Kato M, Arihiro S, Hokari A, Saruta M. Arai Y, et al. Among authors: ogawa m. Clin J Gastroenterol. 2020 Dec;13(6):1200-1204. doi: 10.1007/s12328-020-01216-2. Epub 2020 Sep 3. Clin J Gastroenterol. 2020. PMID: 32880812
Correction to: Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report.
Arai Y, Ogawa M, Yamane F, Sumiyoshi N, Arimoto R, Ando Y, Endo D, Nakada T, Sugawara I, Yokoyama H, Shimoyama K, Inomata H, Kawahara Y, Kato M, Arihiro S, Hokari A, Saruta M. Arai Y, et al. Among authors: ogawa m. Clin J Gastroenterol. 2021 Apr;14(2):696. doi: 10.1007/s12328-020-01246-w. Clin J Gastroenterol. 2021. PMID: 32978712 No abstract available.
Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.
Isshi K, Matsuhashi N, Joh T, Higuchi K, Iwakiri K, Kamiya T, Manabe N, Ogawa M, Arihiro S, Haruma K, Nakada K. Isshi K, et al. Among authors: ogawa m. J Gastroenterol. 2019 Jun;54(6):492-500. doi: 10.1007/s00535-019-01546-0. Epub 2019 Jan 23. J Gastroenterol. 2019. PMID: 30673836
4,723 results